April 19, 2021
Interview of Stanislas Veillet, CEO of Biophytis on La Bourse ou la Vide.com (in French).
APRIL 13, 2021
Biophytis Identifies False Report Regarding COVA StudyRead the Press Release
APRIL 7, 2021
Stanislas Veillet, CEO of Biophytis, reviews the company’s latest news in this interview with Laurent Grassin from Journal des Biotechs, covering listing on Nasdaq, Covid-19 clinical studies, expected clinical data in sarcopenia and the legal case with Negma. You can see the interview here
MARCH 22, 2021
Biophytis gives updates on its Phase 2-3 COVA study on COVID-19
MARCH 19, 2021
Judgment of the Paris Commercial Court of March 16, 2021 in the case of Biophytis against Negma Group Ltd